Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $653 thousand versus the consensus estimate of $1.47 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.